What Is Known about Theragnostic Strategies in Colorectal Cancer
Despite the paradigmatic shift occurred in recent years for defined molecular subtypes in the metastatic setting treatment, colorectal cancer (CRC) still remains an incurable disease in most of the cases. Therefore, there is an urgent need for new tools and biomarkers for both early tumor diagnosis...
Główni autorzy: | , , , , , , |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
MDPI AG
2021-02-01
|
Seria: | Biomedicines |
Hasła przedmiotowe: | |
Dostęp online: | https://www.mdpi.com/2227-9059/9/2/140 |